Single arm pilot study to evaluate the effectiveness of oolong tea in upper gastrointestinal endoscopy

Not Applicable

• Conditions: Person planning screening upper gastrointestinal endoscopy

• Registration Number: JPRN-UMIN000040070
• Lead Sponsor: Osaka Center for Cancer and Cardiovascular Disease Prevention

Brief Summary

Five people were enrolled in this study. The mean age was 55.4 years (SD 6.0). One was male and four were female. The mean examination time was 456 seconds (SD 74.9). The mean of total mucosal visibility score was 14.8 (SD 3.9). Since simethicone/Pronase was additionally used in 2 cases, this study was discontinued in accordance with the protocol. In 4 of 5 cases, the effectiveness of drinking oolong tea in improving visibility was hardly observed.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-04-06
• Study Completion: 2021-05-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

Not provided

Exclusion Criteria

1)History of pharyngeal, esophageal, stomach, or duodenal surgery 2)History of allergy to oolong tea

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mucosal visibility score

Secondary Outcome Measures

Name	Time	Method
Examination time